Department of Acute Infectious Disease Prevention and Control (Emergency Response Office), Kunming Center for Disease Control and Prevention, Kunming, Yunnan Province, China.
Department of Microbiological experiment, Kunming Center for Disease Control and Prevention, Kunming, Yunnan Province, China.
BMC Infect Dis. 2024 Sep 4;24(1):918. doi: 10.1186/s12879-024-09830-y.
On March 16th 2024, the first case of Human infection with avian influenza H10N3 since the end of the global COVID-19 Pandemic was reported in Kunming, China. To enhance comprehension of the source of infection and risk factors of the H10N3 virus infection, this case report summarizes the clinical features, epidemiological investigation, and laboratory test results. Provides recommendations for the prevention and control of Human infection with avian influenza H10N3.
A 51-year-old male with a history of COVID-19 infection and a smoking habit of 30 years, worked in livestock breeding and was exposed to sick and dead poultry before falling ill with fever and chills on 28th February 2024. A week later, he was diagnosed with severe pneumonia, influenza, and respiratory failure by the Third People's Hospital of Kunming(KM-TPH). He was discharged on 17th April and none of his 6 close contacts showed any symptoms of illness. Environmental samples taken from the epidemic spot revealed that peacock feces tested positive for avian influenza sub-type H9 and waterfowl specimens showed positive results for avian influenza sub-type H5. Gene sequencing conducted on positive specimens from the patient's respiratory tract by the Chinese Centre for Disease Control and Prevention (CCDC) showed a high degree of similarity (98.6-99.5%) with the strain responsible for the second global case of human infected with H10N3 (reported from Zhejiang, China 2022).
According to the available epidemiological information, there is limited evidence to suggest that H10N3 viruses are excessively lethal. However, adaptive site mutations have been observed in the H10N3 isoform of mammals. While it is unlikely that the H10N3 virus will spread among humans, the possibility of additional cases cannot be entirely ruled out. Symptoms of human infection with H10N3 avian influenza are similar to those of common respiratory infections, which may result in them being overlooked during initial clinical consultations. Therefore, it is essential to improve surveillance of the H10 sub-type of avian influenza and to increase the awareness of hospital-related workers of cases of pneumonia of unknown origin.
2024 年 3 月 16 日,中国昆明报告了全球 COVID-19 大流行结束以来首例人类感染禽流感 H10N3 病例。为了提高对 H10N3 病毒感染源和危险因素的认识,本病例报告总结了临床特征、流行病学调查和实验室检测结果。为预防和控制人类感染 H10N3 禽流感提供建议。
一名 51 岁男性,有 COVID-19 感染史,有 30 年吸烟史,从事家畜养殖工作,在 2024 年 2 月 28 日发热寒战发病前接触过病禽和死禽。一周后,他被昆明第三人民医院(KM-TPH)诊断为重症肺炎、流感和呼吸衰竭。他于 4 月 17 日出院,他的 6 名密切接触者均未出现任何疾病症状。从疫情现场采集的环境样本显示,孔雀粪便检测出禽流感亚型 H9 呈阳性,水禽标本检测出禽流感亚型 H5 呈阳性。中国疾病预防控制中心(CCDC)对患者呼吸道阳性标本进行基因测序,结果显示与第二例全球人感染 H10N3 病例(中国浙江 2022 年报告)的株高度相似(98.6-99.5%)。
根据现有的流行病学信息,没有证据表明 H10N3 病毒具有过高的致死率。然而,已经观察到哺乳动物 H10N3 亚型的适应性位点突变。虽然 H10N3 病毒不太可能在人群中传播,但不能完全排除出现更多病例的可能性。人类感染 H10N3 禽流感的症状与常见呼吸道感染相似,这可能导致它们在最初的临床咨询中被忽视。因此,必须加强对 H10 亚型禽流感的监测,并提高医院相关工作人员对不明原因肺炎病例的认识。